| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.58 | 0.03 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |